-
Neuropsychiatric Disease and Treatment
-
About Dovepress
Open access peer-reviewed scientific and medical journals.
-
Open Access
Dove Medical Press is now a member of the Open Access Initiative
-
An Author's Guide
A guide to help authors get their paper published.
-
Advocacy
Support Open Access and Dove Press
-
Reprints
Promotional Article Monitoring - further details
-
Favored Author Program
Real benefits for authors, including fast-track processing of papers.
The under-recognition of depression in Parkinson's disease
(2692) Views (27) Full article downloads
Authors: Irene Hegeman Richard, Roger Kurlan
Published Date October 2006
Volume 2006:2(3) Pages 349 - 353
DOI: http://dx.doi.org/10.2147/NDT.S
Irene Hegeman Richard, Roger Kurlan
Department of Neurology, University of Rochester Medical Center, Rochester, NY, USA
Abstract: Depression is common in patients with Parkinson’s disease (PD) and has been identified as the main factor negatively impacting quality of life. It has been reported that depression in PD is under-recognized and under-treated. We report on 90 patients with PD who completed the Geriatric Depression Rating Scale (GDS). Thirteen subjects (14%) scored above 15, the proposed cut-off for diagnosing depression in this illness. Detailed medical record review for these subjects revealed that depression was recognized and treated in only about one-half of the cases. Comparison of mean subscale scores between subjects scoring above and below the cut-off for diagnosis of depression revealed that each of 6 proposed subscales effectively distinguished the two groups. Review of individual items demonstrated that many of the subjects endorsed low energy, regardless of whether they were depressed. This study supports the notion that efforts should be made to educate patients, caregivers and physicians about identifying depression in PD. The routine use of a depression rating scale may facilitate the recognition of depression in this illness.
Keywords: Parkinson’s disease, depression, rating scales, diagnosis
Readers of this article also read:
Topiramate in the prevention of migraine: a review of its efficacy, tolerability, and acceptability
Zonisamide - a review of experience and use in partial seizures
Religiosity in patients with Parkinson's disease
Neurotransmitter testing of the urine: a comprehensive analysis
A pilot study differentiating recurrent major depression from bipolar disorder cycling on the depressive pole
Treatment of attention deficit hyperactivity disorder with monoamine amino acid precursors and organic cation transporter assay interpretation
Amino acid management of Parkinson’s disease: a case study
Neuroimmune endocrine effects of antidepressants
Delivering hydrophilic and hydrophobic chemotherapeutics simultaneously by magnetic mesoporous silica nanoparticles to inhibit cancer cells
- Have an opinion about one of our articles?
We encourage you to write a Letter to the Editor
- Journal Indexing
See where all the Dove Press journals are indexed
- Testimonials
"... I was impressed at the rapidity of publication from submission to final acceptance." Dr Edwin Thrower, PhD, Yale University
- Long-term treatment of bipolar disorder with a radioelectric asymmetric conveyor
- Implementing the 2009 Institute of Medicine recommendations on resident physician work hours, supervision, and safety
- Moderate alcohol consumption and cognitive risk
- Topiramate in the prevention and treatment of migraine: efficacy, safety and patient preference




